Cutler Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,200
Closed -$2K 4611
2022
Q3
$2K Sell
3,200
-3,000
-48% -$289K ﹤0.01% 4181
2022
Q2
$17K Sell
6,200
-1,300
-17% -$135K ﹤0.01% 2795
2022
Q1
$47K Buy
+7,500
New +$841K ﹤0.01% 2291
2021
Q3
Sell
-2,700
Closed -$10K 5871
2021
Q2
$10K Sell
2,700
-3,000
-53% -$283K ﹤0.01% 3889
2021
Q1
$18K Buy
+5,700
New +$482K ﹤0.01% 3290
2019
Q4
Sell
-10,500
Closed -$12K 4138
2019
Q3
$12K Sell
10,500
-4,500
-30% -$316K ﹤0.01% 2508
2019
Q2
$3K Sell
15,000
-3,000
-17% -$181K ﹤0.01% 3353
2019
Q1
$16K Sell
18,000
-2,700
-13% -$154K ﹤0.01% 2181
2018
Q4
$35K Buy
20,700
+16,500
+393% +$835K ﹤0.01% 1702
2018
Q3
$65K Hold
4,200
﹤0.01% 1441
2018
Q2
$32K Hold
4,200
﹤0.01% 1878
2018
Q1
$30K Sell
4,200
-5,700
-58% -$248K ﹤0.01% 2005
2017
Q4
$35K Sell
9,900
-97,500
-91% -$3.58M ﹤0.01% 2135
2017
Q3
$40K Buy
107,400
+48,600
+83% +$1.85M ﹤0.01% 2450
2017
Q2
$106K Sell
58,800
-5,700
-9% -$208K ﹤0.01% 1820
2017
Q1
$37K Sell
64,500
-49,500
-43% -$1.55M ﹤0.01% 2689
2016
Q4
$90K Buy
114,000
+47,400
+71% +$1.54M ﹤0.01% 1995
2016
Q3
$209K Sell
66,600
-6,900
-9% -$260K 0.01% 1169
2016
Q2
$86K Sell
73,500
-600
-0.8% -$20.5K ﹤0.01% 1822
2016
Q1
$134K Sell
74,100
-133,800
-64% -$3.69M 0.01% 1337
2015
Q4
$865K Buy
+207,900
New +$5.4M 0.05% 387

Other funds holding EW

Cutler Group's EW Position: Q1 2024 in Review

Cutler Group sold out of Edwards Lifesciences (EW) in Q1 2024, closing a stake of 207 shares — an estimated $15K sold.

Cutler Group first reported a position in EW in Q4 2015 and held it in 17 quarters. The position peaked at $2.29M in Q2 2016. 1,279 funds tracked by Wall St. Rank hold EW as of Q1 2024.

  • Cutler Group reported no remaining Edwards Lifesciences position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 207 Edwards Lifesciences shares in Q1 2024, an estimated $15K.
  • Cutler Group first reported a position in Edwards Lifesciences in Q4 2015 and held it in 17 quarters.
  • Cutler Group's Edwards Lifesciences position peaked at $2.29M in Q2 2016.
  • 1,279 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.